| Front | Immunotherapeutic drug given to lung cancer patients with PD-L1 expression. |
|---|---|
| Back | Pembrolizumab. |
Learn with these flashcards. Click next, previous, or up to navigate to more flashcards for this subject.
Next card: Small cells characteristic histology carcinomas lungs poorly differentiated
Previous card: Pd-l1 present non-small cell carcinoma
Up to card list: Chapter 9: Respiratory Tract Pathology